nodes	percent_of_prediction	percent_of_DWPC	metapath
Nebivolol—hypertension—type 2 diabetes mellitus	0.622	1	CtDrD
Nebivolol—ADRB1—Bromocriptine—type 2 diabetes mellitus	0.0713	0.326	CbGbCtD
Nebivolol—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0571	0.261	CbGbCtD
Nebivolol—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0264	0.121	CbGbCtD
Nebivolol—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0244	0.112	CbGbCtD
Nebivolol—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.02	0.0917	CbGbCtD
Nebivolol—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0192	0.0879	CbGbCtD
Nebivolol—Erectile dysfunction—Ramipril—type 2 diabetes mellitus	0.000198	0.0017	CcSEcCtD
Nebivolol—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.000198	0.0017	CcSEcCtD
Nebivolol—Angioedema—Valsartan—type 2 diabetes mellitus	0.000197	0.0017	CcSEcCtD
Nebivolol—Malnutrition—Metformin—type 2 diabetes mellitus	0.000197	0.00169	CcSEcCtD
Nebivolol—Pruritus—Glipizide—type 2 diabetes mellitus	0.000196	0.00169	CcSEcCtD
Nebivolol—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000196	0.00169	CcSEcCtD
Nebivolol—Angioedema—Orlistat—type 2 diabetes mellitus	0.000195	0.00168	CcSEcCtD
Nebivolol—Vertigo—Valsartan—type 2 diabetes mellitus	0.000194	0.00167	CcSEcCtD
Nebivolol—Syncope—Valsartan—type 2 diabetes mellitus	0.000194	0.00167	CcSEcCtD
Nebivolol—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000192	0.00165	CcSEcCtD
Nebivolol—Vertigo—Orlistat—type 2 diabetes mellitus	0.000192	0.00165	CcSEcCtD
Nebivolol—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000191	0.00165	CcSEcCtD
Nebivolol—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000191	0.00164	CcSEcCtD
Nebivolol—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000191	0.00164	CcSEcCtD
Nebivolol—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.00019	0.00164	CcSEcCtD
Nebivolol—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00019	0.00164	CcSEcCtD
Nebivolol—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.00019	0.00164	CcSEcCtD
Nebivolol—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.00019	0.00163	CcSEcCtD
Nebivolol—Acute coronary syndrome—Ramipril—type 2 diabetes mellitus	0.000189	0.00163	CcSEcCtD
Nebivolol—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000188	0.00162	CcSEcCtD
Nebivolol—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000188	0.00162	CcSEcCtD
Nebivolol—Myocardial infarction—Ramipril—type 2 diabetes mellitus	0.000188	0.00162	CcSEcCtD
Nebivolol—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000188	0.00162	CcSEcCtD
Nebivolol—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000186	0.0016	CcSEcCtD
Nebivolol—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000186	0.0016	CcSEcCtD
Nebivolol—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000186	0.0016	CcSEcCtD
Nebivolol—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000186	0.0016	CcSEcCtD
Nebivolol—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000185	0.0016	CcSEcCtD
Nebivolol—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000185	0.00159	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000184	0.00159	CcSEcCtD
Nebivolol—Chest pain—Valsartan—type 2 diabetes mellitus	0.000184	0.00158	CcSEcCtD
Nebivolol—Dizziness—Glipizide—type 2 diabetes mellitus	0.000184	0.00158	CcSEcCtD
Nebivolol—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000183	0.00158	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000183	0.00157	CcSEcCtD
Nebivolol—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000182	0.00157	CcSEcCtD
Nebivolol—Chest pain—Orlistat—type 2 diabetes mellitus	0.000182	0.00156	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.00018	0.00155	CcSEcCtD
Nebivolol—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000177	0.00153	CcSEcCtD
Nebivolol—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000177	0.00152	CcSEcCtD
Nebivolol—Vomiting—Glipizide—type 2 diabetes mellitus	0.000176	0.00152	CcSEcCtD
Nebivolol—Syncope—Metformin—type 2 diabetes mellitus	0.000176	0.00152	CcSEcCtD
Nebivolol—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000176	0.00151	CcSEcCtD
Nebivolol—Rash—Glipizide—type 2 diabetes mellitus	0.000175	0.00151	CcSEcCtD
Nebivolol—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000175	0.00151	CcSEcCtD
Nebivolol—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000175	0.0015	CcSEcCtD
Nebivolol—Headache—Glipizide—type 2 diabetes mellitus	0.000174	0.0015	CcSEcCtD
Nebivolol—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000174	0.00149	CcSEcCtD
Nebivolol—Shock—Valsartan—type 2 diabetes mellitus	0.000173	0.00149	CcSEcCtD
Nebivolol—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000173	0.00149	CcSEcCtD
Nebivolol—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000173	0.00149	CcSEcCtD
Nebivolol—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000173	0.00149	CcSEcCtD
Nebivolol—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000172	0.00148	CcSEcCtD
Nebivolol—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000171	0.00147	CcSEcCtD
Nebivolol—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000171	0.00147	CcSEcCtD
Nebivolol—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000171	0.00147	CcSEcCtD
Nebivolol—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000171	0.00147	CcSEcCtD
Nebivolol—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000171	0.00147	CcSEcCtD
Nebivolol—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000171	0.00147	CcSEcCtD
Nebivolol—Urticaria—Glyburide—type 2 diabetes mellitus	0.00017	0.00146	CcSEcCtD
Nebivolol—Angioedema—Irbesartan—type 2 diabetes mellitus	0.00017	0.00146	CcSEcCtD
Nebivolol—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000169	0.00146	CcSEcCtD
Nebivolol—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000169	0.00146	CcSEcCtD
Nebivolol—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000169	0.00145	CcSEcCtD
Nebivolol—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000168	0.00144	CcSEcCtD
Nebivolol—Chest pain—Metformin—type 2 diabetes mellitus	0.000167	0.00144	CcSEcCtD
Nebivolol—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000167	0.00144	CcSEcCtD
Nebivolol—Headache—Pioglitazone—type 2 diabetes mellitus	0.000167	0.00143	CcSEcCtD
Nebivolol—Syncope—Irbesartan—type 2 diabetes mellitus	0.000166	0.00143	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000166	0.00143	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000166	0.00143	CcSEcCtD
Nebivolol—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000165	0.00142	CcSEcCtD
Nebivolol—Nausea—Glipizide—type 2 diabetes mellitus	0.000165	0.00142	CcSEcCtD
Nebivolol—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000165	0.00142	CcSEcCtD
Nebivolol—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000164	0.00141	CcSEcCtD
Nebivolol—Rash—Glimepiride—type 2 diabetes mellitus	0.000163	0.00141	CcSEcCtD
Nebivolol—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000163	0.0014	CcSEcCtD
Nebivolol—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000163	0.0014	CcSEcCtD
Nebivolol—Rash—Sitagliptin—type 2 diabetes mellitus	0.000163	0.0014	CcSEcCtD
Nebivolol—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000163	0.0014	CcSEcCtD
Nebivolol—Headache—Glimepiride—type 2 diabetes mellitus	0.000162	0.0014	CcSEcCtD
Nebivolol—Headache—Sitagliptin—type 2 diabetes mellitus	0.000162	0.00139	CcSEcCtD
Nebivolol—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00016	0.00138	CcSEcCtD
Nebivolol—Angioedema—Losartan—type 2 diabetes mellitus	0.00016	0.00137	CcSEcCtD
Nebivolol—Insomnia—Valsartan—type 2 diabetes mellitus	0.000159	0.00137	CcSEcCtD
Nebivolol—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000158	0.00136	CcSEcCtD
Nebivolol—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000158	0.00136	CcSEcCtD
Nebivolol—Shock—Metformin—type 2 diabetes mellitus	0.000158	0.00136	CcSEcCtD
Nebivolol—Insomnia—Orlistat—type 2 diabetes mellitus	0.000158	0.00136	CcSEcCtD
Nebivolol—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000157	0.00136	CcSEcCtD
Nebivolol—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000157	0.00136	CcSEcCtD
Nebivolol—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000157	0.00135	CcSEcCtD
Nebivolol—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000157	0.00135	CcSEcCtD
Nebivolol—Vertigo—Losartan—type 2 diabetes mellitus	0.000157	0.00135	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000157	0.00135	CcSEcCtD
Nebivolol—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000157	0.00135	CcSEcCtD
Nebivolol—Somnolence—Valsartan—type 2 diabetes mellitus	0.000157	0.00135	CcSEcCtD
Nebivolol—Syncope—Losartan—type 2 diabetes mellitus	0.000157	0.00135	CcSEcCtD
Nebivolol—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000156	0.00135	CcSEcCtD
Nebivolol—Skin disorder—Metformin—type 2 diabetes mellitus	0.000156	0.00134	CcSEcCtD
Nebivolol—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000155	0.00133	CcSEcCtD
Nebivolol—Nausea—Glimepiride—type 2 diabetes mellitus	0.000154	0.00132	CcSEcCtD
Nebivolol—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000154	0.00132	CcSEcCtD
Nebivolol—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000153	0.00132	CcSEcCtD
Nebivolol—Asthenia—Glyburide—type 2 diabetes mellitus	0.000153	0.00132	CcSEcCtD
Nebivolol—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000152	0.00131	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000152	0.00131	CcSEcCtD
Nebivolol—Fatigue—Valsartan—type 2 diabetes mellitus	0.000152	0.00131	CcSEcCtD
Nebivolol—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000152	0.00131	CcSEcCtD
Nebivolol—Pruritus—Glyburide—type 2 diabetes mellitus	0.000151	0.0013	CcSEcCtD
Nebivolol—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000151	0.0013	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.00015	0.00129	CcSEcCtD
Nebivolol—Fatigue—Orlistat—type 2 diabetes mellitus	0.00015	0.00129	CcSEcCtD
Nebivolol—Malnutrition—Ramipril—type 2 diabetes mellitus	0.00015	0.00129	CcSEcCtD
Nebivolol—Shock—Irbesartan—type 2 diabetes mellitus	0.000149	0.00128	CcSEcCtD
Nebivolol—Chest pain—Losartan—type 2 diabetes mellitus	0.000149	0.00128	CcSEcCtD
Nebivolol—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000149	0.00128	CcSEcCtD
Nebivolol—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000149	0.00128	CcSEcCtD
Nebivolol—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000148	0.00128	CcSEcCtD
Nebivolol—Rash—Bromocriptine—type 2 diabetes mellitus	0.000147	0.00127	CcSEcCtD
Nebivolol—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000147	0.00127	CcSEcCtD
Nebivolol—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000147	0.00127	CcSEcCtD
Nebivolol—Headache—Bromocriptine—type 2 diabetes mellitus	0.000146	0.00126	CcSEcCtD
Nebivolol—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000146	0.00126	CcSEcCtD
Nebivolol—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000144	0.00124	CcSEcCtD
Nebivolol—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000144	0.00124	CcSEcCtD
Nebivolol—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000143	0.00123	CcSEcCtD
Nebivolol—Somnolence—Metformin—type 2 diabetes mellitus	0.000143	0.00123	CcSEcCtD
Nebivolol—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000142	0.00123	CcSEcCtD
Nebivolol—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000141	0.00122	CcSEcCtD
Nebivolol—Shock—Losartan—type 2 diabetes mellitus	0.00014	0.00121	CcSEcCtD
Nebivolol—Urticaria—Valsartan—type 2 diabetes mellitus	0.00014	0.00121	CcSEcCtD
Nebivolol—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.00014	0.0012	CcSEcCtD
Nebivolol—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.00014	0.0012	CcSEcCtD
Nebivolol—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000139	0.0012	CcSEcCtD
Nebivolol—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000139	0.0012	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000139	0.00119	CcSEcCtD
Nebivolol—Fatigue—Metformin—type 2 diabetes mellitus	0.000138	0.00119	CcSEcCtD
Nebivolol—Urticaria—Orlistat—type 2 diabetes mellitus	0.000138	0.00119	CcSEcCtD
Nebivolol—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000138	0.00119	CcSEcCtD
Nebivolol—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000138	0.00119	CcSEcCtD
Nebivolol—Angioedema—Ramipril—type 2 diabetes mellitus	0.000137	0.00118	CcSEcCtD
Nebivolol—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000136	0.00117	CcSEcCtD
Nebivolol—Vomiting—Glyburide—type 2 diabetes mellitus	0.000136	0.00117	CcSEcCtD
Nebivolol—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000136	0.00117	CcSEcCtD
Nebivolol—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000135	0.00116	CcSEcCtD
Nebivolol—Rash—Glyburide—type 2 diabetes mellitus	0.000135	0.00116	CcSEcCtD
Nebivolol—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000135	0.00116	CcSEcCtD
Nebivolol—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000135	0.00116	CcSEcCtD
Nebivolol—Vertigo—Ramipril—type 2 diabetes mellitus	0.000135	0.00116	CcSEcCtD
Nebivolol—Syncope—Ramipril—type 2 diabetes mellitus	0.000134	0.00116	CcSEcCtD
Nebivolol—Headache—Glyburide—type 2 diabetes mellitus	0.000134	0.00115	CcSEcCtD
Nebivolol—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000132	0.00113	CcSEcCtD
Nebivolol—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000131	0.00113	CcSEcCtD
Nebivolol—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000131	0.00113	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000131	0.00113	CcSEcCtD
Nebivolol—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000131	0.00112	CcSEcCtD
Nebivolol—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00013	0.00112	CcSEcCtD
Nebivolol—Insomnia—Losartan—type 2 diabetes mellitus	0.000129	0.00111	CcSEcCtD
Nebivolol—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000128	0.0011	CcSEcCtD
Nebivolol—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000128	0.0011	CcSEcCtD
Nebivolol—Urticaria—Metformin—type 2 diabetes mellitus	0.000128	0.0011	CcSEcCtD
Nebivolol—Chest pain—Ramipril—type 2 diabetes mellitus	0.000127	0.0011	CcSEcCtD
Nebivolol—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000127	0.00109	CcSEcCtD
Nebivolol—Nausea—Glyburide—type 2 diabetes mellitus	0.000127	0.00109	CcSEcCtD
Nebivolol—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000127	0.00109	CcSEcCtD
Nebivolol—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000127	0.00109	CcSEcCtD
Nebivolol—Somnolence—Losartan—type 2 diabetes mellitus	0.000127	0.00109	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000127	0.00109	CcSEcCtD
Nebivolol—Asthenia—Valsartan—type 2 diabetes mellitus	0.000126	0.00109	CcSEcCtD
Nebivolol—Asthenia—Orlistat—type 2 diabetes mellitus	0.000125	0.00108	CcSEcCtD
Nebivolol—Pruritus—Valsartan—type 2 diabetes mellitus	0.000125	0.00107	CcSEcCtD
Nebivolol—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000124	0.00107	CcSEcCtD
Nebivolol—Pruritus—Orlistat—type 2 diabetes mellitus	0.000123	0.00106	CcSEcCtD
Nebivolol—Fatigue—Losartan—type 2 diabetes mellitus	0.000123	0.00106	CcSEcCtD
Nebivolol—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000122	0.00105	CcSEcCtD
Nebivolol—Rash—Gliclazide—type 2 diabetes mellitus	0.000121	0.00104	CcSEcCtD
Nebivolol—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000121	0.00104	CcSEcCtD
Nebivolol—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000121	0.00104	CcSEcCtD
Nebivolol—Urticaria—Irbesartan—type 2 diabetes mellitus	0.00012	0.00104	CcSEcCtD
Nebivolol—Shock—Ramipril—type 2 diabetes mellitus	0.00012	0.00104	CcSEcCtD
Nebivolol—Headache—Gliclazide—type 2 diabetes mellitus	0.00012	0.00103	CcSEcCtD
Nebivolol—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.00012	0.00103	CcSEcCtD
Nebivolol—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.00012	0.00103	CcSEcCtD
Nebivolol—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.00012	0.00103	CcSEcCtD
Nebivolol—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000119	0.00103	CcSEcCtD
Nebivolol—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000119	0.00102	CcSEcCtD
Nebivolol—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000117	0.001	CcSEcCtD
Nebivolol—Dizziness—Valsartan—type 2 diabetes mellitus	0.000117	0.001	CcSEcCtD
Nebivolol—Dizziness—Orlistat—type 2 diabetes mellitus	0.000115	0.000992	CcSEcCtD
Nebivolol—Asthenia—Metformin—type 2 diabetes mellitus	0.000115	0.000991	CcSEcCtD
Nebivolol—Nausea—Gliclazide—type 2 diabetes mellitus	0.000114	0.000981	CcSEcCtD
Nebivolol—Pruritus—Metformin—type 2 diabetes mellitus	0.000114	0.000978	CcSEcCtD
Nebivolol—Urticaria—Losartan—type 2 diabetes mellitus	0.000113	0.000975	CcSEcCtD
Nebivolol—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000113	0.00097	CcSEcCtD
Nebivolol—Vomiting—Valsartan—type 2 diabetes mellitus	0.000112	0.000965	CcSEcCtD
Nebivolol—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000112	0.000961	CcSEcCtD
Nebivolol—Rash—Valsartan—type 2 diabetes mellitus	0.000111	0.000957	CcSEcCtD
Nebivolol—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000111	0.000956	CcSEcCtD
Nebivolol—Vomiting—Orlistat—type 2 diabetes mellitus	0.000111	0.000953	CcSEcCtD
Nebivolol—Insomnia—Ramipril—type 2 diabetes mellitus	0.000111	0.000952	CcSEcCtD
Nebivolol—Headache—Valsartan—type 2 diabetes mellitus	0.00011	0.000951	CcSEcCtD
Nebivolol—Diarrhoea—Metformin—type 2 diabetes mellitus	0.00011	0.000946	CcSEcCtD
Nebivolol—Rash—Orlistat—type 2 diabetes mellitus	0.00011	0.000945	CcSEcCtD
Nebivolol—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.00011	0.000945	CcSEcCtD
Nebivolol—Dermatitis—Orlistat—type 2 diabetes mellitus	0.00011	0.000945	CcSEcCtD
Nebivolol—Headache—Orlistat—type 2 diabetes mellitus	0.000109	0.000939	CcSEcCtD
Nebivolol—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000109	0.000938	CcSEcCtD
Nebivolol—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000109	0.000936	CcSEcCtD
Nebivolol—Somnolence—Ramipril—type 2 diabetes mellitus	0.000109	0.000936	CcSEcCtD
Nebivolol—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000107	0.000923	CcSEcCtD
Nebivolol—Dizziness—Metformin—type 2 diabetes mellitus	0.000106	0.000914	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000106	0.000909	CcSEcCtD
Nebivolol—Fatigue—Ramipril—type 2 diabetes mellitus	0.000105	0.000907	CcSEcCtD
Nebivolol—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000105	0.000904	CcSEcCtD
Nebivolol—Nausea—Valsartan—type 2 diabetes mellitus	0.000105	0.000901	CcSEcCtD
Nebivolol—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000104	0.000892	CcSEcCtD
Nebivolol—Nausea—Orlistat—type 2 diabetes mellitus	0.000103	0.000891	CcSEcCtD
Nebivolol—Asthenia—Losartan—type 2 diabetes mellitus	0.000102	0.000881	CcSEcCtD
Nebivolol—Vomiting—Metformin—type 2 diabetes mellitus	0.000102	0.000879	CcSEcCtD
Nebivolol—Rash—Metformin—type 2 diabetes mellitus	0.000101	0.000871	CcSEcCtD
Nebivolol—Dermatitis—Metformin—type 2 diabetes mellitus	0.000101	0.000871	CcSEcCtD
Nebivolol—Pruritus—Losartan—type 2 diabetes mellitus	0.000101	0.000868	CcSEcCtD
Nebivolol—Headache—Metformin—type 2 diabetes mellitus	0.000101	0.000866	CcSEcCtD
Nebivolol—Dizziness—Irbesartan—type 2 diabetes mellitus	0.0001	0.000862	CcSEcCtD
Nebivolol—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	9.99e-05	0.000861	CcSEcCtD
Nebivolol—Diarrhoea—Losartan—type 2 diabetes mellitus	9.75e-05	0.00084	CcSEcCtD
Nebivolol—Urticaria—Ramipril—type 2 diabetes mellitus	9.71e-05	0.000836	CcSEcCtD
Nebivolol—Abdominal pain—Ramipril—type 2 diabetes mellitus	9.66e-05	0.000832	CcSEcCtD
Nebivolol—Vomiting—Irbesartan—type 2 diabetes mellitus	9.63e-05	0.000829	CcSEcCtD
Nebivolol—Rash—Irbesartan—type 2 diabetes mellitus	9.55e-05	0.000822	CcSEcCtD
Nebivolol—Dermatitis—Irbesartan—type 2 diabetes mellitus	9.54e-05	0.000821	CcSEcCtD
Nebivolol—Nausea—Metformin—type 2 diabetes mellitus	9.53e-05	0.000821	CcSEcCtD
Nebivolol—Headache—Irbesartan—type 2 diabetes mellitus	9.49e-05	0.000817	CcSEcCtD
Nebivolol—Dizziness—Losartan—type 2 diabetes mellitus	9.43e-05	0.000812	CcSEcCtD
Nebivolol—Vomiting—Losartan—type 2 diabetes mellitus	9.06e-05	0.00078	CcSEcCtD
Nebivolol—Hypersensitivity—Ramipril—type 2 diabetes mellitus	9.01e-05	0.000775	CcSEcCtD
Nebivolol—Nausea—Irbesartan—type 2 diabetes mellitus	9e-05	0.000775	CcSEcCtD
Nebivolol—Rash—Losartan—type 2 diabetes mellitus	8.99e-05	0.000774	CcSEcCtD
Nebivolol—Dermatitis—Losartan—type 2 diabetes mellitus	8.98e-05	0.000773	CcSEcCtD
Nebivolol—Headache—Losartan—type 2 diabetes mellitus	8.93e-05	0.000769	CcSEcCtD
Nebivolol—Asthenia—Ramipril—type 2 diabetes mellitus	8.77e-05	0.000755	CcSEcCtD
Nebivolol—Pruritus—Ramipril—type 2 diabetes mellitus	8.65e-05	0.000745	CcSEcCtD
Nebivolol—Nausea—Losartan—type 2 diabetes mellitus	8.47e-05	0.000729	CcSEcCtD
Nebivolol—Diarrhoea—Ramipril—type 2 diabetes mellitus	8.36e-05	0.00072	CcSEcCtD
Nebivolol—Dizziness—Ramipril—type 2 diabetes mellitus	8.08e-05	0.000696	CcSEcCtD
Nebivolol—Vomiting—Ramipril—type 2 diabetes mellitus	7.77e-05	0.000669	CcSEcCtD
Nebivolol—Rash—Ramipril—type 2 diabetes mellitus	7.71e-05	0.000664	CcSEcCtD
Nebivolol—Dermatitis—Ramipril—type 2 diabetes mellitus	7.7e-05	0.000663	CcSEcCtD
Nebivolol—Headache—Ramipril—type 2 diabetes mellitus	7.66e-05	0.000659	CcSEcCtD
Nebivolol—Nausea—Ramipril—type 2 diabetes mellitus	7.26e-05	0.000625	CcSEcCtD
Nebivolol—ADRB2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	1.08e-05	0.000248	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	1.08e-05	0.000248	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.08e-05	0.000246	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.07e-05	0.000245	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.07e-05	0.000245	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—UCP2—type 2 diabetes mellitus	1.07e-05	0.000245	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—UCP3—type 2 diabetes mellitus	1.07e-05	0.000245	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—HSD11B1—type 2 diabetes mellitus	1.07e-05	0.000245	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—AGT—type 2 diabetes mellitus	1.07e-05	0.000244	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	1.06e-05	0.000243	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PSMD6—type 2 diabetes mellitus	1.06e-05	0.000242	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—HTR2C—type 2 diabetes mellitus	1.06e-05	0.000242	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.05e-05	0.000241	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.05e-05	0.000241	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.05e-05	0.00024	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.05e-05	0.00024	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.05e-05	0.00024	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.05e-05	0.00024	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—AGT—type 2 diabetes mellitus	1.04e-05	0.000239	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.04e-05	0.000237	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.03e-05	0.000236	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.03e-05	0.000236	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.03e-05	0.000235	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.03e-05	0.000235	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.03e-05	0.000235	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.03e-05	0.000235	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.01e-05	0.000232	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.01e-05	0.000231	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.01e-05	0.00023	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PCK1—type 2 diabetes mellitus	1.01e-05	0.00023	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PLAT—type 2 diabetes mellitus	1e-05	0.00023	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—GHRL—type 2 diabetes mellitus	1e-05	0.00023	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CALCA—type 2 diabetes mellitus	9.92e-06	0.000227	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	9.86e-06	0.000225	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	9.76e-06	0.000223	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	9.72e-06	0.000222	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	9.64e-06	0.00022	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—GCG—type 2 diabetes mellitus	9.6e-06	0.000219	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	9.6e-06	0.000219	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	9.55e-06	0.000218	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	9.51e-06	0.000217	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	9.44e-06	0.000216	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—HK1—type 2 diabetes mellitus	9.43e-06	0.000216	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	9.41e-06	0.000215	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	9.39e-06	0.000215	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—GCG—type 2 diabetes mellitus	9.39e-06	0.000215	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	9.34e-06	0.000214	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	9.3e-06	0.000213	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	9.24e-06	0.000211	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	9.21e-06	0.000211	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	9.18e-06	0.00021	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—GCG—type 2 diabetes mellitus	9.18e-06	0.00021	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	9.1e-06	0.000208	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	9.1e-06	0.000208	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	9.1e-06	0.000208	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	9.1e-06	0.000208	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	9.03e-06	0.000207	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	9e-06	0.000206	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	8.98e-06	0.000205	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	8.83e-06	0.000202	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	8.82e-06	0.000202	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	8.79e-06	0.000201	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	8.73e-06	0.0002	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	8.63e-06	0.000197	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	8.63e-06	0.000197	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	8.59e-06	0.000196	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	8.44e-06	0.000193	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	8.43e-06	0.000193	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	8.35e-06	0.000191	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—GNB3—type 2 diabetes mellitus	8.27e-06	0.000189	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	8.17e-06	0.000187	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MMP3—type 2 diabetes mellitus	8.16e-06	0.000187	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—AVP—type 2 diabetes mellitus	8.16e-06	0.000187	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IGF2—type 2 diabetes mellitus	8.13e-06	0.000186	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	8.11e-06	0.000186	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—GNB3—type 2 diabetes mellitus	8.09e-06	0.000185	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	8.09e-06	0.000185	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	8.01e-06	0.000183	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	7.99e-06	0.000183	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—AVP—type 2 diabetes mellitus	7.98e-06	0.000183	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MMP3—type 2 diabetes mellitus	7.98e-06	0.000183	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IGF2—type 2 diabetes mellitus	7.95e-06	0.000182	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	7.91e-06	0.000181	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—GNB3—type 2 diabetes mellitus	7.91e-06	0.000181	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—APOB—type 2 diabetes mellitus	7.89e-06	0.00018	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	7.86e-06	0.00018	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	7.83e-06	0.000179	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MMP3—type 2 diabetes mellitus	7.81e-06	0.000179	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—AVP—type 2 diabetes mellitus	7.81e-06	0.000179	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IGF2—type 2 diabetes mellitus	7.77e-06	0.000178	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—EDN1—type 2 diabetes mellitus	7.76e-06	0.000178	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	7.74e-06	0.000177	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—APOB—type 2 diabetes mellitus	7.72e-06	0.000176	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	7.69e-06	0.000176	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	7.66e-06	0.000175	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—EDN1—type 2 diabetes mellitus	7.59e-06	0.000174	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	7.57e-06	0.000173	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—APOB—type 2 diabetes mellitus	7.55e-06	0.000173	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—LPL—type 2 diabetes mellitus	7.53e-06	0.000172	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	7.52e-06	0.000172	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—EDN1—type 2 diabetes mellitus	7.43e-06	0.00017	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	7.42e-06	0.00017	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	7.42e-06	0.00017	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	7.37e-06	0.000169	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—LPL—type 2 diabetes mellitus	7.37e-06	0.000168	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	7.28e-06	0.000166	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	7.23e-06	0.000165	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	7.23e-06	0.000165	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	7.23e-06	0.000165	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	7.21e-06	0.000165	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—LPL—type 2 diabetes mellitus	7.21e-06	0.000165	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	7.19e-06	0.000164	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	7.07e-06	0.000162	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	7.06e-06	0.000161	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	7.05e-06	0.000161	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	6.98e-06	0.00016	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.94e-06	0.000159	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.91e-06	0.000158	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.79e-06	0.000155	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—C3—type 2 diabetes mellitus	6.78e-06	0.000155	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.76e-06	0.000155	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.64e-06	0.000152	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—C3—type 2 diabetes mellitus	6.63e-06	0.000152	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—C3—type 2 diabetes mellitus	6.49e-06	0.000148	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	6.49e-06	0.000148	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	6.49e-06	0.000148	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	6.49e-06	0.000148	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.47e-06	0.000148	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.45e-06	0.000148	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—AGT—type 2 diabetes mellitus	6.44e-06	0.000147	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	6.37e-06	0.000146	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.34e-06	0.000145	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.33e-06	0.000145	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—LEP—type 2 diabetes mellitus	6.31e-06	0.000144	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—APOE—type 2 diabetes mellitus	6.31e-06	0.000144	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.31e-06	0.000144	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	6.31e-06	0.000144	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—AGT—type 2 diabetes mellitus	6.3e-06	0.000144	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.24e-06	0.000143	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.2e-06	0.000142	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.19e-06	0.000141	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—APOE—type 2 diabetes mellitus	6.18e-06	0.000141	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—LEP—type 2 diabetes mellitus	6.18e-06	0.000141	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	6.17e-06	0.000141	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.17e-06	0.000141	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—AGT—type 2 diabetes mellitus	6.16e-06	0.000141	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.11e-06	0.00014	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.06e-06	0.000139	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—APOE—type 2 diabetes mellitus	6.04e-06	0.000138	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—LEP—type 2 diabetes mellitus	6.04e-06	0.000138	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.97e-06	0.000137	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.95e-06	0.000136	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	5.93e-06	0.000136	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	5.87e-06	0.000134	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	5.87e-06	0.000134	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.82e-06	0.000133	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	5.72e-06	0.000131	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.7e-06	0.00013	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.63e-06	0.000129	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	5.62e-06	0.000129	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	5.62e-06	0.000129	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.51e-06	0.000126	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—INS—type 2 diabetes mellitus	5.39e-06	0.000123	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.39e-06	0.000123	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.31e-06	0.000121	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—INS—type 2 diabetes mellitus	5.28e-06	0.000121	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.22e-06	0.000119	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.21e-06	0.000119	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.19e-06	0.000119	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.19e-06	0.000119	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—INS—type 2 diabetes mellitus	5.16e-06	0.000118	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.1e-06	0.000117	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.1e-06	0.000117	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.08e-06	0.000116	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.08e-06	0.000116	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.99e-06	0.000114	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.99e-06	0.000114	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.97e-06	0.000114	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.95e-06	0.000113	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	4.85e-06	0.000111	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.85e-06	0.000111	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.85e-06	0.000111	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	4.83e-06	0.00011	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	4.76e-06	0.000109	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.74e-06	0.000108	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.73e-06	0.000108	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.73e-06	0.000108	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.63e-06	0.000106	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.63e-06	0.000106	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	4.62e-06	0.000106	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.52e-06	0.000103	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.52e-06	0.000103	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	4.5e-06	0.000103	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—RELA—type 2 diabetes mellitus	4.45e-06	0.000102	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	4.41e-06	0.000101	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—RELA—type 2 diabetes mellitus	4.36e-06	9.96e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	4.32e-06	9.88e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	4.31e-06	9.84e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—RELA—type 2 diabetes mellitus	4.26e-06	9.74e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	4.19e-06	9.59e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	4.14e-06	9.47e-05	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.05e-06	9.27e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.02e-06	9.18e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.99e-06	9.12e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	3.97e-06	9.08e-05	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.97e-06	9.07e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.93e-06	8.98e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.9e-06	8.92e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	3.9e-06	8.91e-05	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.88e-06	8.86e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.84e-06	8.78e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.82e-06	8.73e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.8e-06	8.68e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	3.78e-06	8.63e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.75e-06	8.59e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.71e-06	8.49e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	3.71e-06	8.49e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	3.7e-06	8.46e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.68e-06	8.42e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.67e-06	8.4e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	3.66e-06	8.36e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.63e-06	8.3e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.6e-06	8.23e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.59e-06	8.21e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.52e-06	8.05e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	3.5e-06	8e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—SRC—type 2 diabetes mellitus	3.42e-06	7.83e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.41e-06	7.79e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	3.35e-06	7.65e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.33e-06	7.62e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.26e-06	7.45e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	3.22e-06	7.37e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	3.16e-06	7.23e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.13e-06	7.15e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.07e-06	7.01e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.06e-06	7e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—EGFR—type 2 diabetes mellitus	3e-06	6.86e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.99e-06	6.84e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.93e-06	6.71e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	2.9e-06	6.62e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	2.77e-06	6.34e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.77e-06	6.34e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	2.53e-06	5.8e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.36e-06	5.39e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IL6—type 2 diabetes mellitus	2.31e-06	5.27e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	2.25e-06	5.15e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.17e-06	4.97e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.13e-06	4.86e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.08e-06	4.76e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.27e-06	2.91e-05	CbGpPWpGaD
